Portal de Periódicos da CAPES

Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia

2019; Ferrata Storti Foundation; Volume: 105; Issue: 2 Linguagem: Inglês

10.3324/haematol.2019.219550

1592-8721

Fary Diop, Riccardo Moia, Chiara Favini, Elisa Spaccarotella, Lorenzo De Paoli, Alessio Bruscaggin, Valeria Spina, Lodovico Terzi-di-Bergamo, Francesca Arruga, Chiara Tarantelli, Clara Deambrogi, Silvia Rasi, Ramesh Adhinaveni, Andrea Patriarca, Simone Favini, Sruthi Sagiraju, Clive Jabangwe, Ahad Ahmed Kodipad, Denise Peroni, Francesca Romana Mauro, Ilaria Del Giudice, Francesco Forconi, Agostino Cortelezzi, Francesco Zaja, Riccardo Bomben, Francesca Maria Rossi, Carlo Visco, Annalisa Chiarenza, Gian Matteo Rigolin, Roberto Marasca, Marta Coscia, Omar Perbellini, Alessandra Tedeschi, Luca Laurenti, Marina Motta, D. Donaldson, Philip Weir, Ken Mills, Patrick Thornton, Sarah Lawless, Francesco Bertoni, Giovanni Del Poeta, Antonio Cuneo, Antonia Follenzi, Valter Gattei, Renzo Boldorini, Mark Catherwood, Silvia Deaglio, Robin Foà, Gianluca Gaïdano, Davide Rossi,

Cell death mechanisms and regulation

is a recurrently mutated gene in chronic lymphocytic leukemia (CLL) but the functional implications of